Related Experiment Videos
[Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken)]
Insights
Visken effectively treated heart rhythm disturbances in acute myocardial infarction patients. Beta-blockade therapy is recommended when other antiarrhythmic drugs fail and heart rate is elevated.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Acute myocardial infarction (AMI) patients often experience dangerous ectopic rhythms.
- Conventional antiarrhythmic drugs may be insufficient for certain arrhythmias in AMI.
Purpose:
- To evaluate the efficacy and safety of Visken (pindolol) in treating ventricular and atrial arrhythmias in AMI patients.
- To determine the role of beta-blockade in managing these rhythm disturbances.
Summary:
- Visken was administered intravenously (0.4 mg x 3 doses) to 40 AMI patients with ectopic beats or tachycardia.
- The study demonstrated a positive effect of Visken on cardiac rhythm disturbances.
- Treatment was found to be safe when contraindications were considered.
Impact:
- Visken offers a viable therapeutic option for specific arrhythmias in AMI.
- Beta-blockade with Visken is particularly beneficial for patients with elevated sinus rates unresponsive to other treatments.
Abstract:
In a group of 40 patients with acute myocardial infarction and ectopic ventricular or atrial beats or tachycardia, the effect of Visken has been tested by means of 3 i.v. injections of 0.4 mg each at intervals of 15 min. The results showed that Visken has a good effect on these rhythm disturbances and can be administered without danger, provided due regard is had to the contraindications. Beta-blockade is especially indicated when the sinus rate is raised and the conventional antiarrhythmic drugs have proved ineffective.